Works matching IS 17597706 AND DT 2021 AND VI 12 AND IP 2
Results: 18
Comparison of adequacy between transbronchial lung cryobiopsy samples and endobronchial ultrasound‐guided transbronchial needle aspiration samples for next‐generation sequencing analysis.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 2, p. 251, doi. 10.1111/1759-7714.13770
- By:
- Publication type:
- Article
Effect of durvalumab on local control after concurrent chemoradiotherapy for locally advanced non‐small cell lung cancer in comparison with chemoradiotherapy alone.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 2, p. 245, doi. 10.1111/1759-7714.13764
- By:
- Publication type:
- Article
Dabrafenib and trametinib therapy in an elderly patient with non‐small cell lung cancer harboring the BRAF V600E mutation.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 2, p. 272, doi. 10.1111/1759-7714.13756
- By:
- Publication type:
- Article
Clinical implication of minimal presence of solid or micropapillary subtype in early‐stage lung adenocarcinoma.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 2, p. 235, doi. 10.1111/1759-7714.13754
- By:
- Publication type:
- Article
Postoperative radiotherapy for pathological stage IIIA‐N2 non‐small cell lung cancer with positive surgical margins.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 2, p. 227, doi. 10.1111/1759-7714.13749
- By:
- Publication type:
- Article
Immune microenvironment features and efficacy of PD‐1/PD‐L1 blockade in non‐small cell lung cancer patients with EGFR or HER2 exon 20 insertions.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 2, p. 218, doi. 10.1111/1759-7714.13748
- By:
- Publication type:
- Article
MiR‐423‐5p aggravates lung adenocarcinoma via targeting CADM1.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 2, p. 210, doi. 10.1111/1759-7714.13745
- By:
- Publication type:
- Article
Validating impact of pretreatment tumor growth rate on outcome of early‐stage lung cancer treated with stereotactic body radiation therapy.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 2, p. 201, doi. 10.1111/1759-7714.13744
- By:
- Publication type:
- Article
Tissue surface area and tumor cell count affect the success rate of the Oncomine Dx Target Test in the analysis of biopsy tissue samples.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 2, p. 194, doi. 10.1111/1759-7714.13743
- By:
- Publication type:
- Article
RNF213 gene mutation in circulating tumor DNA detected by targeted next‐generation sequencing in the assisted discrimination of early‐stage lung cancer from pulmonary nodules.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 2, p. 181, doi. 10.1111/1759-7714.13741
- By:
- Publication type:
- Article
Treatment strategy for primary lung cancer in a lung highly compressed by giant emphysematous bullae: A case report.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 2, p. 268, doi. 10.1111/1759-7714.13739
- By:
- Publication type:
- Article
Osimertinib combined with bevacizumab for leptomeningeal metastasis from EGFR‐mutation non‐small cell lung cancer: A phase II single‐arm prospective clinical trial.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 2, p. 172, doi. 10.1111/1759-7714.13738
- By:
- Publication type:
- Article
Long‐term outcomes of sentinel node identification using indocyanine green in patients with lung cancer.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 2, p. 165, doi. 10.1111/1759-7714.13737
- By:
- Publication type:
- Article
Outcome and risk factor of immune‐related adverse events and pneumonitis in patients with advanced or postoperative recurrent non‐small cell lung cancer treated with immune checkpoint inhibitors.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 2, p. 153, doi. 10.1111/1759-7714.13736
- By:
- Publication type:
- Article
Anti‐PD‐1 therapy plus chemotherapy showed superior and durable survival benefit in a patient with small cell esophageal cancer: A case report.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 2, p. 264, doi. 10.1111/1759-7714.13735
- By:
- Publication type:
- Article
Autologous cytokine‐induced killer (CIK) cells enhance the clinical response to PD‐1 blocking antibodies in patients with advanced non‐small cell lung cancer: A preliminary study.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 2, p. 145, doi. 10.1111/1759-7714.13731
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 2, p. 143, doi. 10.1111/1759-7714.13508
- Publication type:
- Article
Complete response of squamous cell carcinoma of the lung following treatment with pembrolizumab in an elderly patient: A case report.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 2, p. 259, doi. 10.1111/1759-7714.13733
- By:
- Publication type:
- Article